Sandoz Group AG (OTCMKTS:SDZNY - Get Free Report) shot up 1.6% during mid-day trading on Friday . The stock traded as high as $49.39 and last traded at $49.28. 27,703 shares changed hands during mid-day trading, a decline of 29% from the average session volume of 38,795 shares. The stock had previously closed at $48.50.
Wall Street Analysts Forecast Growth
SDZNY has been the subject of several analyst reports. Royal Bank of Canada raised shares of Sandoz Group from a "hold" rating to a "moderate buy" rating in a report on Friday, May 2nd. UBS Group lowered Sandoz Group from a "strong-buy" rating to a "hold" rating in a report on Monday, February 3rd.
Check Out Our Latest Stock Analysis on Sandoz Group
Sandoz Group Stock Performance
The firm's 50 day moving average is $42.95 and its 200 day moving average is $43.86.
About Sandoz Group
(
Get Free Report)
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
Read More
Before you consider Sandoz Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sandoz Group wasn't on the list.
While Sandoz Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
